Tumor progression and increased cell invasiveness following cathepsin B release are also characteristic for pancreatic ductal adenocarcinoma [123], esophageal adenocarcinoma [124], and glioma, where cathepsins K and X were also found to be involved [125,126,127]. This evidence concerns the gene CTSB and glioma.